Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Added to Bupivacaine for Post-Op Analgesia in ACL Reconstruction
NCT06665438Phase 3Recruiting
- Sponsor
- Al-Azhar University
- Start
- Dec 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Al-Azhar University. Primary endpoint: Visual Analog Scale for Pain at 24 hours. Started Dec 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06665438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06665438.